Literature DB >> 34150604

Ropivacaine: A Novel Local Anaesthetic Drug to Use in Otorhinolaryngology Practice.

Nagalingeswaran Ahilasamy1, Rajendran Dinesh Kumar2, Hem Anand Nayagam3, Omprakash Shanmuganandam3, K R Vaibhavi2, Vishakha Modak2.   

Abstract

Ropivacaine is a long-acting amide local anaesthetic agent which has a significant vasoconstrictive property, long duration of action, least central nervous system and cardiac complications due to the pure (S)-enantiomer property by reversible inhibition of sodium ion influx in nerve fibres. By using additives the duration of analgesia may be prolonged. Ropivacaine has been used routinely in our otorhinolaryngology procedures since 2010 (10 years). The present article details the clinical applications of ropivacaine and its current place as a local anaesthetic in otorhinolaryngology practice. © Springer Nature India Private Limited part of Springer Nature 2021.

Entities:  

Keywords:  Anaesthesia; ENT surgeries; Regional anaesthetic; Ropivacaine

Year:  2021        PMID: 34150604      PMCID: PMC8163903          DOI: 10.1007/s12070-020-02309-7

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  22 in total

1.  The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats.

Authors:  P Dony; V Dewinde; B Vanderick; O Cuignet; P Gautier; E Legrand; P Lavand'homme; M De Kock
Journal:  Anesth Analg       Date:  2000-12       Impact factor: 5.108

Review 2.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Paravertebral Nerve Block for Donor Site Pain in Stage I Microtia Reconstruction: A Pilot Study.

Authors:  Amber D Shaffer; Noel Jabbour; Mihaela Visoiu; Charles I Yang; Robert F Yellon
Journal:  Otolaryngol Head Neck Surg       Date:  2016-02-23       Impact factor: 3.497

4.  Comparison of ropivacaine, bupivacaine, prilocaine, and lidocaine in the management of pain and hemorrhage during nasal pack removal.

Authors:  Zeliha Kapusuz Gencer; Mahmut Ozkiriş; Muzaffer Gencer; Levent Saydam
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

5.  Comparison of ropivacaine, bupivacaine and lidocaine in the management of post-tonsillectomy pain.

Authors:  Mahmut Ozkiriş; Zeliha Kapusuz; Levent Saydam
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2012-09-27       Impact factor: 1.675

6.  The effect of lidocaine, bupivacaine and ropivacaine in nasal packs on pain and hemorrhage after septoplasty.

Authors:  Emin Karaman; Gurcan Gungor; Yalcin Alimoglu; Erkan Kilic; Eylem Tarakci; Pervin Bozkurt; Ozgun Enver
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-01       Impact factor: 2.503

7.  Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.

Authors:  G Ekström; U B Gunnarsson
Journal:  Drug Metab Dispos       Date:  1996-09       Impact factor: 3.922

8.  Ropivacaine with or without clonidine improves pediatric tonsillectomy pain.

Authors:  C Giannoni; S White; F K Enneking; T Morey
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-10

9.  Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties.

Authors:  Bernhard M Graf; Ingo Abraham; Nicole Eberbach; Gudrun Kunst; David F Stowe; Eike Martin
Journal:  Anesthesiology       Date:  2002-06       Impact factor: 7.892

10.  Continuous lesser palatine nerve block for postoperative analgesia after uvulopalatopharyngoplasty.

Authors:  Nathaniel A Ponstein; Tae-Wu Edward Kim; Jennifer Hsia; Richard Goode; Paula Borges; Edward R Mariano
Journal:  Clin J Pain       Date:  2013-12       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.